Mustang Bio, Inc.
MBIO
$0.61
-$0.02-3.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.92M | -2.34M | -3.28M | -10.71M | -15.75M |
| Total Depreciation and Amortization | 41.00K | 116.00K | 167.00K | 168.00K | 823.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.70M | -217.00K | -403.00K | 1.55M | 1.76M |
| Change in Net Operating Assets | -1.68M | -3.11M | -2.97M | 1.52M | 1.76M |
| Cash from Operations | -5.26M | -5.54M | -6.48M | -7.48M | -11.41M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 1.17M | 1.17M | 1.17M | 1.17M | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1.17M | 1.17M | 1.17M | 1.17M | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.76M | 19.70M | 13.57M | 18.83M | 11.27M |
| Repurchase of Common Stock | -235.00K | -235.00K | -235.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.53M | 19.46M | 13.33M | 18.83M | 11.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.43M | 15.08M | 8.01M | 12.52M | -145.00K |